Centro Radiologico Plaza Baquedano
Santiago, Region Metropolitana, Chile
Radiologist in Providencia, Chile
Vicuña Mackenna 4, Providencia, Región Metropolitana
About Centro Radiologico Plaza Baquedano
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
2
Clinical Trials at Centro Radiologico Plaza Baquedano
During the past decade, Centro Radiologico Plaza Baquedano conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of Abrocitinib Compared With Dupilumab in Adults With Moderate to Severe Atopic Dermatitis on Background Topical Therapy
2020-06-11
2021-07-13
Completed
727
TO ASSESS THE EFFICACY AND SAFETY OF PF-06650833, PF-06651600, AND TOFACITINIB ALONE AND IN COMBINATION IN PARTICIPANTS WITH ACTIVE RHEUMATOID ARTHRITIS WITH AN INADEQUATE RESPONSE TO METHOTREXATE
2020-07-29
2022-02-07
Completed
460
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Centro Radiologico Plaza Baquedano
According to Clinical.Site data, the most researched conditions in "Centro Radiologico Plaza Baquedano" are
"Atopic Dermatitis" (1 trials) and "Rheumatoid Arthritis" (1 trials). Many other conditions were trialed in "Centro Radiologico Plaza Baquedano" in a lesser frequency.
Clinical Trials Intervention Types at Centro Radiologico Plaza Baquedano
Most popular intervention types in "Centro Radiologico Plaza Baquedano" are "Drug" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.
The name of intervention was led by "Abrocitinib 200 mg" (1 trials), "Dupilumab 300 mg" (1 trials), "PF-06650833" (1 trials), "PF-06651600" (1 trials) and "Tofacitinib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Centro Radiologico Plaza Baquedano
The vast majority of trials in "Centro Radiologico Plaza Baquedano" are
2 trials for "All" genders.
Clinical Trials Status at Centro Radiologico Plaza Baquedano
Currently, there are NaN active trials in "Centro Radiologico Plaza Baquedano".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Centro Radiologico Plaza Baquedano,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Centro Radiologico Plaza Baquedano, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".